Press Release | Mon Aug 26, 2013 1:05am EDT

CEPTARIS RECEIVES US FDA APPROVAL FOR VALCHLOR - A SIGNIFICANT CLOSING CONDITION OF ACTELION'S ACQUISITION OF PRIVATELY-HELD CEPTARIS

* Reuters is not responsible for the content in this press release.